Non small cell lung cancer medical therapy: Difference between revisions

	Small Cell Carcinoma of the Lung Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Small Cell Carcinoma of the Lung from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Radiation Therapy
Surgery
Prevention
Future or Investigational Therapies
Case Studies
Case #1
Non small cell lung cancer medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Non small cell lung cancer medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Non small cell lung cancer medical therapy
CDC on Non small cell lung cancer medical therapy
Non small cell lung cancer medical therapy in the news
Blogs on Non small cell lung cancer medical therapy
Directions to Hospitals Treating Small cell carcinoma of the lung
Risk calculators and risk factors for Non small cell lung cancer medical therapy

Revision as of 15:41, 24 June 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2]

@@ Line 8: / Line 8: @@
 {{NSCLC stage III medical therapy}}
-==Chemotherapy plus radiotherapy regimens==
-===Chemotherapy plus radiotherapy===
-The list bellow show the options for concomitant [[chemotherapy]] plus [[radiation therapy]] based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref>
-*[[Cisplatin]] 50 mg/m<sup>2</sup> on days 1, 8, 29 and 36 + [[etoposide]] 50 mg/m<sup>2</sup> through days 1 to 5 and then 29 to 33 + thoracic radiotherapy
-*[[Cisplatin]] 100 mg/m<sup>2</sup> on days 1 and 29 + vinblastin 5 mg/m<sup>2</sup> weekly for 5 weeks + thoracic radiotherapy
-*[[Cisplatin]] 75 mg/m<sup>2</sup> on the first day + [[pemetrexed]] 500 mg/m<sup>2</sup> on day 1 and then every 21 days to a total of 3 cycles + thoracic radiotherapy
-*Carboplatin (AUC) 5 on the first day + [[pemetrexed]] 500 mg/m<sup>2</sup> on day 1 and then every 21 days to a total of 3 cycles + thoracic radiotherapy
-===Chemotherapy followed by radiotherapy===
-===Chemotherapy plus radiotherapy, followed by chemotherapy===
 ==References==
 {{reflist|2}}